ml 116

ML116 is a potent and selective STAT3 inhibitor.

Anticanceragent 260 (Compound 3g/4d) is an orally effective anticancer agent that inhibits the proliferation of cancer cells HCT-116, MIA-PaCa2, and MDA-MB231, with IC50 values of 98.7, 81.0, and 77.2 µg/mL, respectively. It also promotes ulcer formation and lipid peroxidation, and exhibits anti-inflammatory and analgesic activities.

Antimicrobial agent-32 (Compound 4g) is an antibacterial compound with significant efficacy against several bacteria, including Staphylococcus aureus, Bacillus subtilis, Bacillus cereus [MIC=1000 µg/mL], Klebsiella pneumonia, and methicillin-resistant Staphylococcus aureus [MRSA] [MIC=500 µg/mL], as well as Escherichia coli [MIC=250 µg/mL]. Additionally, Antimicrobial agent-32 exhibits anticancer activity by inhibiting the proliferation of MCF-7, HCT-116, and HepG-2 cells.

Curcuphenol in concentrations in the range of 29-116 µg/ml inhibited cell proliferation and DNA replication and induced cell death in a dose-dependent manner.

Verrucarin J (Muconomycin B), derived from the Myrothecium fungus family, effectively generates reactive oxygen species (ROS) to induce apoptosis in various cancer cell lines, including A549, HCT 116, and SW-620. Besides its anticancer properties, it exhibits antifungal activity against Candida albicans and Mucor miehei. Furthermore, it notably inhibits the arenavirus Junin (JUNV) yield with an IC 50 of 1.2 ng/mL.

Rostratin A, a cytotoxic disulfide isolated from the marine-derived fungus Exserohilum rostratum, demonstrates in vitro cytotoxicity against human colon carcinoma (HCT-116), exhibiting an inhibitory concentration 50 (IC 50) value of 8.5 μg/mL.

Rostratin B, a cytotoxic disulfide, exhibits in vitro cytotoxicity against human colon carcinoma (HCT-116) with an IC50 value of 1.9 μg/mL.

Rostratin C, a cytotoxic disulfide, exhibits in vitro cytotoxicity against human colon carcinoma (HCT-116) with an IC50 value of 0.76 μg/mL.

Diaporthein B, a highly oxidized pimarane diterpene, demonstrates significant activity against M. tuberculosis with a MIC of 3.1 μg/mL and exhibits IC50 values ranging from 1.5-3 μM/L against HCT 116 and LoVo colon cancer cells [1].

Eponemycin is an antibiotic with antitumor properties. It exhibits cytotoxicity against cancer cell lines B16-F10, L1210, P388, and HCT-116, with IC50 values of 0.0017, 0.01, 0.031, and 0.0097 µg/mL, respectively. In B16-F10 and mitomycin C, Eponemycin inhibits DNA synthesis, with IC50 values of 0.1 µg/mL and 0.41 µg/mL, respectively.

Cystothiazole A exhibits antifungal properties, effectively inhibiting Candida albicans, Saccharomyces cerevisiae, and Aspergillus fumigatus with minimum inhibitory concentrations (MIC) of 0.4 μg/mL, 0.1 μg/mL, and 1.6 μg/mL, respectively. It also demonstrates inhibitory activity against human tumor cells such as HPT-116 and K562, with MIC values of 130 ng/mL and 110 ng/mL. However, it shows no antibacterial activity.

Pradimicin Q is an antibiotic exhibiting cytotoxicity against human colon HCT-116 cells and mouse melanoma B16-F10 cells, with IC50 values of 75 μg/mL and 100 μg/mL, respectively.

Citreamicin alpha (LL-E 19085-alpha) is an antibiotic that has been evaluated for its in vitro antibacterial activity against 429 clinical isolates of Gram-positive cocci using the agar dilution method. This study included 313 strains of staphylococci and 116 strains of streptococci. Its in vitro efficacy was compared with ampicillin, amoxicillin, cephalothin, erythromycin, and vancomycin. For staphylococci, Citreamicin alpha demonstrated MIC values ranging from 0.12 to 4.0 μg/ml, and for Streptococcus pyogenes, the MIC values ranged from 0.03 to 0.12 μg/ml. Conversely, enterococci presented relative resistance, requiring 2.0 μg/ml to inhibit 64% of 62 tested strains. The antibiotic's in vitro efficacy significantly surpassed that of ampicillin, amoxicillin, cephalothin, and erythromycin, while it was comparable to or slightly less effective than vancomycin.

Delphinidin 3-O-glucoside is a natural product with anti-inflammatory and antioxidant properties. It inhibits NF-κB in mesenchymal stem cells and increases the S/G2/M cell cycle, while reducing IL-1β, IL-12, TNF-α synthesis in macrophages, reduces PD-L1 protein expression in HCT-116 cells, and inhibits cell growth (IC50 = 396 ± 23 µg/mL).